Type 2 asthma paediatric patients eligible for dupilumab: An Italian biomarker-based analysis.

Piacentini G, Fiocchi A, Marseglia G, Miraglia Del Giudice M, Cutrera R, Bitonti R, Fanelli F, Stassaldi A, Nicolosi G, Furneri G

Open source

DOI: 10.1016/j.waojou.2024.100933
Published: 2024 Aug
Container: The World Allergy Organization journal
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.waojou.2024.100933,
  title = {Type 2 asthma paediatric patients eligible for dupilumab: An Italian biomarker-based analysis.},
  author = {Piacentini G and Fiocchi A and Marseglia G and Miraglia Del Giudice M and Cutrera R and Bitonti R and Fanelli F and Stassaldi A and Nicolosi G and Furneri G},
  year = {2024},
  journal = {The World Allergy Organization journal},
  doi = {10.1016/j.waojou.2024.100933},
  url = {https://doi.org/10.1016/j.waojou.2024.100933}
}

RIS

TY  - JOUR
TI  - Type 2 asthma paediatric patients eligible for dupilumab: An Italian biomarker-based analysis.
AU  - Piacentini G
AU  - Fiocchi A
AU  - Marseglia G
AU  - Miraglia Del Giudice M
AU  - Cutrera R
AU  - Bitonti R
AU  - Fanelli F
AU  - Stassaldi A
AU  - Nicolosi G
AU  - Furneri G
PY  - 2024
JO  - The World Allergy Organization journal
DO  - 10.1016/j.waojou.2024.100933
UR  - https://doi.org/10.1016/j.waojou.2024.100933
ER  -

APA

G, P., A, F., G, M., M, M. D. G., R, C., R, B., F, F., A, S., G, N., & G, F. (2024). Type 2 asthma paediatric patients eligible for dupilumab: An Italian biomarker-based analysis.. The World Allergy Organization journal. https://doi.org/10.1016/j.waojou.2024.100933

Source records

pubmed · retrieved 2026-09-26T17:16:40.725Z